CN

Colleen Nelson

UC University Of British Columbia: 10 patents #42 of 1,308Top 4%
TI Teva Pharmaceutical Industries: 2 patents #183 of 489Top 40%
📍 Surrey, CA: #40 of 718 inventorsTop 6%
Overall (All Time): #420,638 of 4,157,543Top 15%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
9095602 Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides Martin E. Gleave, Paul S. Rennie, Hideaki Miyake, Tobias Zellweger 2015-08-04
9074209 TRPM-2 antisense therapy Martin E. Gleave, Paul S. Rennie, Hideaki Miyake 2015-07-07
8536149 TRPM-2 antisense therapy Martin E. Gleave, Paul S. Rennie, Hideaki Miyake 2013-09-17
8361981 Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides Martin E. Gleave, Paul S. Rennie, Hideaki Miyake, Tobias Zellweger 2013-01-29
8173615 TRPM-2 antisense therapy Martin E. Gleave, Paul S. Rennie, Hideaki Miyake 2012-05-08
7732422 TRPM-2 antisense therapy Martin E. Gleave, Paul S. Rennie, Hideaki Miyake 2010-06-08
7592323 TRPM-2 antisense therapy Martin E. Gleave, Paul S. Rennie, Hideaki Miyake 2009-09-22
7569551 Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides Martin E. Gleave, Paul S. Rennie, Hikeaki Miyake, Tobias Zellweger 2009-08-04
7534773 TRPM-2 antisense therapy Martin E. Gleave, Paul S. Rennie, Hideaki Miyake 2009-05-19
7368436 TRPM-2 antisense therapy Martin E. Gleave, Paul S. Rennie, Hideaki Miyake 2008-05-06
7196067 Antisense insulin-like growth factor binding protein (IGFBP)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy Martin E. Gleave, Paul S. Rennie, Kiyama Satoshi 2007-03-27
6900187 TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications Martin E. Gleave, Paul S. Rennie, Hideaki Miyake, Brett P. Monia 2005-05-31